HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sustainable Cosmetics Summit In Brief

This article was originally published in The Rose Sheet

Executive Summary

Organic Monitor President Amarjit Sahota suggests that the natural industry is nearing a “green glass ceiling” in terms of consumers open to green messaging and brands. More news from the Sustainable Cosmetics Summit in New York.

You may also be interested in...



U.S. Next Target In Cruelty Free’s Crusade For Global Animal-Test Ban

Cruelty Free International calls on FDA to follow the EU’s example and ban animal testing for cosmetic products and ingredients. The group has launched a new campaign to generate support among American consumers while inviting visitors to its website to sign a global pledge to end cosmetic animal testing worldwide.

Dr. Bronner’s Joins WFTO, Takes Jab At Fair Trade USA

Dr. Bronner’s Magic Soaps joins the World Fair Trade Organization, which recognizes “fully committed” fair-trade brands, it says. The organic personal-care maker seizes the opportunity to contrast WFTO’s program with that of Fair Trade USA.

Naturals Sector Should Work To Promote Sustainable Marine Sourcing

With “blue sourcing” – the harvesting of marine ingredients for personal-care products – expected to increase in the coming years, consulting firm Organic Monitor suggests that natural industry veterans could favorably influence marine sourcing practices to help ensure sustainability.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel